Little is known about how long it takes for new medicines to reach countries with different income levels. We analyzed data, sourced from IQVIA, on the timing of new drug launches in seventy-five low- ...
Little is known about hospital indemnity insurance in the Medicare context; in this article, we propose an initial research ...
No child should be disenrolled from, or not enrolled in, the coverage to which they are entitled due to faulty systems and ...
The answer to improving disability data collection is not to retain the current ACS-6 but to adopt tested questions that use ...
The two question sets yield different estimates of the prevalence of disability in the United States, as has been ...
A recent decision in Oregon signals that federal courts may be wary of interfering with efforts by state legislatures to ...
If CMS cannot persuade GRAIL of the importance of randomization and using cancer death as the outcome, then it should cancel ...
Health Affairs' Editor-in-Chief Alan Weil interviews Dr. Jay Bhatt, Managing Director of the Deloitte Center for Health Solutions and the Deloitte Health Equity Institute, to highlight the upcoming ...
Health Affairs' Editor-in-Chief Alan Weil interviews Dr. Jay Bhatt, Managing Director of the Deloitte Center for Health Solutions and the Deloitte Health Equity Institute, to highlight the ...